Is Your Etelcalcetide API Clouding Your CaSR Assays?
Jun 23, 2026
Leave a message
Is Your Etelcalcetide API Clouding Your CaSR Assays? A Researcher's Guide to 99% Molecular Purity
Navigating Structural Reality, Receptor Kinase Calibration, and High-Throughput Consistency in Synthetic Peptide Sourcing
Why Does HPLC Purity Below 99.0% Sabotage Endocrine Suppression?
B2B procurement teams and research laboratories frequently approach us with a recurring challenge: "Why do our experimental models show inconsistent endocrine suppression across different peptide lots?"
The diagnosis is always structural. In the synthesis of Etelcalcetide (CAS 1262780-97-1), achieving "almost pure" is a clinical non-starter. This molecule relies on a highly precise D-amino acid configuration disulfide-linked to a D-cysteine moiety. If your raw material falls below the ≥ 99.0% purity threshold, the resulting unreacted intermediates or truncated sequences don't just act as dead weight-they actively cloud your affinity assays.
To understand why our high-content synthetic Etelcalcetide 99% sets the benchmark for research outcomes, we must look at the exact biophysical binding site. Unlike traditional small-molecule calcimimetics that act as allosteric modulators at the transmembrane domain, Etelcalcetide establishes a specific disulfide bond covalent linkage directly with a D-cysteine residue on the extracellular domain of the CaSR. If the material contains even 1.5% of oxidized peptide dimers, those steric anomalies block the receptor's active site without triggering the necessary conformational change.
Tihealth Forensic Specification Matrix: Etelcalcetide API
| Quality Parameter | Specification (Tihealth Research Grade) | Validation Protocol |
|---|---|---|
| Active Ingredient | Etelcalcetide (High-Purity Pure Peptide) | Standardized Bio-Synthesis |
| CAS Number | 1262780-97-1 | Analytical Registry |
| Molecular Formula | C38H73N21O10S2 | Mass Spectrometry (MS) |
| Molecular Weight | 1048.3 g/mol | ESI-MS Identification |
| Purity Profile | ≥ 99.0% | HPLC Main Peak Integration |
| Source Origin | 100% Synthetic Chain Assembly | Controlled SPPS |
| Physical State | Lyophilized white amorphous powder | Visual Inspection |
How Does Etelcalcetide Systematically Drive the Reduction of iPTH Levels?
For research institutions investigating secondary hyperparathyroidism (SHPT) and metabolic bone disease models, the primary target is the rapid, sustained down-regulation of Parathyroid Hormone (PTH). When high-purity Etelcalcetide targets the parathyroid chief cells, it acts as an ultra-potent calcimimetic via three clear pathways:
- Direct Receptor Activation: By binding to the extracellular domain of CaSR, it enhances the receptor's sensitivity to extracellular calcium ions, essentially convincing the parathyroid gland that blood calcium levels are optimal.
- Rapid Genotypic Down-Regulation: This synthetic activation rapidly suppresses the intracellular transcription of the PTH gene, preventing the overproduction of intact parathyroid hormone at the cellular source.
- Systemic Serum Equilibrium: By shifting the parathyroid's set point, the peptide helps research models manage the complex biochemical loops associated with renal osteodystrophy.
Procurement Note:
Botanical alternatives (e.g., Mentha extracts) cannot substitute for this pathway. Endocrine calcimimetics require highly specialized synthetic peptide architectures like the C38H73N21O10S2 matrix to directly hit systemic parathyroid targets.
Secure Your CaSR Research Pipeline with Verified Specifications
At Xi'an Tihealth Biotechnology Co., Ltd., we mandate that our Etelcalcetide API undergoes rigorous purification to eliminate oxidized peptide dimers and truncated sequences. For procurement directors and advanced laboratories demanding zero-drift results, upgrading your synthetic peptide supply chain is non-negotiable.
- ➤ Verify Technical Specifications for Tihealth Etelcalcetide 99% (CAS 1262780-97-1) - Ultra-pure synthetic peptide engineered for uncompromised calcium-sensing receptor modulation and clinical modeling.
Strategic Sourcing FAQ: Etelcalcetide Formulation
Because this specific sequence is built entirely out of D-amino acids (mirror images of natural L-amino acids), nature's ribosomes cannot synthesize it. 100% Solid-Phase Peptide Synthesis (SPPS) allows us to build the chain step-by-step, ensuring absolute stereochemical control over the unique disulfide bridges. This grants the molecule robust resistance against endogenous proteolytic degradation.
Etelcalcetide contains a critical disulfide bond sensitive to moisture and thermal shifts. Lyophilized powder must be stored at -20°C for long-term archiving, or 2–8°C for short-term testing. Xi'an Tihealth packages bulk shipments in vacuum-sealed, fluorinated HDPE containers backed by dual poly bags, guaranteeing a verifiable 24-month shelf life without a drop in HPLC purity.
Weighing micro-quantities from a 1kg bulk container exposes the entire batch to atmospheric moisture and thaw cycles. We provide fully customizable pre-aliquoted packaging-from 5mg screening vials to multi-kilogram commercial batches. This eliminates secondary handling at your facility and ensures every milligram retains its native ≥ 99.0% molecular potency.
The Xi'an Tihealth Quality Directive
Operating globally under strict ISO9001:2015 principles, Xi'an Tihealth Biotechnology Co., Ltd. eliminates the guesswork from B2B peptide sourcing. Every batch of synthetic Etelcalcetide we deliver includes native, untampered HPLC and Mass Spectrometry (MS) verification profiles, empowering R&D teams to focus on repeatable, clinical-grade breakthroughs.
Scientific References:
- NIH PubChem Compound Summary: Etelcalcetide (CAS 1262780-97-1) Chemical Data.
- The Journal of Clinical Investigation: Mechanism of Covalent Activation of the Extracellular CaSR.
- WHO INN: Structural Nomenclature for Synthetic D-Amino Acid Peptides.
*Compliance Disclaimer: Products protected by valid patents are strictly for R&D and analytical laboratory use only in restricted jurisdictions. Commercial procurement is subject to the intellectual property laws of the final destination country.*
Send Inquiry